Cannara Biotech Inc.
LOVFF
Get informed when a big investor buys or sells
+ FollowMarket Cap$205.47M
Close$
Share Statistics
| Market cap | $205.47 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.14 |
| Beta | 0.39 |
| Outstanding Shares | 98,782,148 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 18.31 |
|---|---|
| PEG | 108.27 |
| Price to Sales | 1.5 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 15, 2026
EPS Estimate
$0.04
Average shareholder expectationRevenue Estimate
$22.63 M
Average shareholder expectationNext Earnings Call
Expected Date
November 23, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$24.65 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Cannara Biotech Inc.
452 employees
CEO: Zohar Krivorot Cannara Biotech Inc., alongside its affiliated entities, specializes in the indoor cultivation, processing, and distribution of cannabis and related products across Canada. The company operates with a dual business model, encompassing bo...